Download PDF

Other users also viewed these articles

Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease Laura Carrasco Hernández; Rosa Mª Girón Moreno; Mari Nieves Balaguer Cartagena; Adrián Peláez; Amparo Sole; Antonio Álvarez Fernández; Almudena Felipe Montiel; Casilda Olveira; Gabriel Olveira; Ainhoa Gómez Bonilla; Beatriz Gómez Crespo; Marta García Clemente; Marta Solís García; Joana Quaresma Vázquez; Enrique Blitz Castro; Jesús Rodríguez González; Andrea Expósito Marrero; Laila Diab-Cáceres; Cristina Ramos Hernández; Ester Zamarrón de Lucas; Concha Prados Sanchez; Marina Blanco Aparicio; Alejandro López Neyra; Verónica Sanz Santiago; Carmen Luna Paredes; Isabel Delgado Pecellín; Óscar Asensio de la Cruz; Esther Quintana Gallego;
Arch Bronconeumol. 2023;59:556-65
[Translated article] Deconstructing phenotypes in COPD: An analysis of the TRACE cohort Laura Carrasco Hernández; Candela Caballero Eraso; Borja Ruiz-Duque; María Abad Arranz; Eduardo Márquez Martín; Carmen Calero Acuña; Jose Luis Lopez-Campos;
Arch Bronconeumol. 2022;58:T30-4
Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD Ciro Casanova; Enrique Gonzalez-Dávila; Juan P de Torres; Carlos Cabrera; Borja G. Cosio; Denis E. O¿Donnel; Cristina Martínez-Gonzalez; Ingrid Solanes; Antonia Fuster; Carolina Gotera; Alicia Marin; Carlos Amado; Marta Iscar; José M Marin; J. Alberto Neder; Nuria Feu; Joan B Soriano; José Luis López-Campos; Miguel Divo; Germán Peces-Barba; Bartolomé R Celli;
10.1016/j.arbres.2025.05.004